Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A1c measurements

Mayo Clinic Proceedings

Volumn 82, Issue 2, 2007, Pages 229-236

  Dailey, George ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

DIABETES MELLITUS; DIET RESTRICTION; DISEASE MARKER; EXPOSURE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GOLD STANDARD; HEMOGLOBIN DETERMINATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MEASUREMENT; PHYSICAL ACTIVITY; POSTPRANDIAL STATE; REVIEW; SELF MONITORING;

EID: 33846669385     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.2.229     Document Type: Review

References (53)

1. EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe [published correction appears in Lancet. 2000;356:1690]. Lancet. 2000;355:873-876.
2. International Diabetes Federation. Diabetes Atlas. 2nd ed. Brussels, Belgium: International Diabetes Federation; 2003.
3. Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care. 2004;27:17-20.
4. Resnick HE, Foster GL, Bardsley J, Ratner RE. Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey. Diabetes Care. 2006;29:531-537.
5. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002;287:2563-2569.
6. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2002;48:436-472.
7. American Diabetes Association. Standards of medical care in diabetes - 2006 [published correction appears in Diabetes Care. 2006;29:1192]. Diabetes Care. 2006;29(suppl 1):S4-S42.
8. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [published correction appears in Lancet. 1999;354:602]. Lancet. 1998;352:837-853.
9. Stratton IM, Adler AI, Neil HAW, et al, UK Prospective Diabetes Study Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-412.
10. 1c interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care. 2001;24:2023-2029.
11. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study [published correction appears in Diabetes Res Clin Pract. 2000;47:225]. Diabetes Res Clin Pract. 1999;46:183-190.
12. Hay LC, Wilmshurst EG, Fulcher G. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring. Diabetes Technol Ther. 2003;5:19-26.
13. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 1995;44:968-983.
14. Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications. 2005;19:178-181.
15. American College of Endocrinology. American College of Endocrinology consensus statement on guidelines for glycemic control. Endocr Pract. 2002;8(suppl 1):5-11.
16. 1c. Diabetes Care. 2003;26:881-885.
17. Bonora E, Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia. 2001;44:2107-2114.
18. Wolever TM, Chiasson JL, Csima A, et al. Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal versus 75 g oral glucose. Diabetes Care. 1998;21:336-340.
19. Gerich JE. Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch Intern Med. 2003;163:1306-1316.
20. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care. 1999;22:920-924.
21. Hanefeld M, Fischer S, Julius U, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia. 1996;39:1577-1583.
22. Esposito K, Giugliano D, Nappo F, Marfella R, Campanian Postprandial Hyperglycemia Study Group. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation. 2004 Jul 13;110:214-219. Epub 2004 Jun 14.
23. 1c in Japanese type 2 diabetic patients [letter]. Diabetes Care. 2005;28:2806-2807.
24. Polgreen PM, Putz D, Stapleton JT. Inaccurate glycosylated hemoglobin A1C measurements in human immunodeficiency virus-positive patients with diabetes mellitus. Clin Infect Dis. 2003 Aug 15;37:e53-e56. Epub 2003 Jul 30.
25. 1c. JAMA. 2006;295:1688-1697.
26. Koch B. Glucose monitoring as a guide to diabetes management: critical subject review. Can Fam Physician. 1996;42:1142-1146, 1149-1152.
27. Mayfield J, Havas S, AAFP Panel on Self-Monitoring of Blood Glucose. Self-control: a physician's guide to blood glucose monitoring in the management of diabetes. Available at: www.aafp.org/online/en/home/publications/otherpubs/ afpmonographs/smbgmonograph.html. Accessed December 27, 2006.
28. Renard E. Monitoring glycemic control: the importance of self-monitoring of blood glucose. Am J Med. 2005;118(suppl 9A):12S-19S.
29. Weinzimer SA, Beck RW, Chase HP, et al, Diabetes Research in Children Network Study Group. Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study. Diabetes Technol Ther. 2005;7:675-680.
30. Arabadjief D, Nichols JH. Assessing glucose meter accuracy. Curr Med Res Opin. 2006;22:2167-2174.
31. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care. 2002;25:275-278.
32. Nathan DM, Turgeon H, Regan S. Translation of glycosylated hemoglobin levels into mean blood glucose (MBG) levels, revisited [abstract]. Diabetes. 2006;55(suppl 1):A96. Abstract 408.5-P.
33. Bode BW, Schwartz S, Stubbs HA, Block JE. Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values. Diabetes Care. 2005;28:2361-2366.
34. Kovatchev BP, Cox DJ, Gonder-Frederick L, Clarke WL. Methods for quantifying self-monitoring blood glucose profiles exemplified by an examination of blood glucose patterns in patients with type 1 and type 2 diabetes. Diabetes Technol Ther. 2002;4:295-303.
35. Erlinger TP, Brancati FL. Postchallenge hyperglycemia in a national sample of U.S. adults with type 2 diabetes. Diabetes Care. 2001;24:1734-1738.
36. Hirsch IB. Blood glucose monitoring technology: translating data into practice. Endocr Pract. 2004;10:67-76.
37. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295:1681-1687.
38. Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications [editorial]. JAMA. 2006;295:1707-1708.
39. Davis WA, Bruce DG, Davis TM. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients?: the Fremantle Diabetes Study. Diabetes Care. 2006;29:1764-1770.
40. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med. 2005;118:422-425.
41. Harris MI. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care. 2001;24:979-982.
42. Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med. 2001;111:1-9.
43. Blonde L, Karter AJ. Current evidence regarding the value of self-monitored blood glucose testing. Am J Med. 2005;118(suppl 9A):20S-26S.
44. Sarol JN Jr, Nicodemus NA Jr, Tan KM, Grava MB. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004). Curr Med Res Opin. 2005;21:173-184.
45. Welschen LM, Bloemendal E, Nijpels G, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care. 2005;28:1510-1517.
46. Karter AJ, Parker MM, Moffet HH, et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care. 2006;29:1757-1763.
47. Martin S, Schneider B, Heinemann L, et al.. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia. 2006 Feb;49:271-278. Epub 2005 Dec 17.
48. American Diabetes Association. Self-monitoring of blood glucose. Diabetes Care. 1994;17:81-86.
49. Goldstein DE, Little RR, Lorenz RA, et al. Tests of glycemia in diabetes. Diabetes Care. 2004;27:1761-1773.
50. Buse JB, Freeman JL, Edelman SV, Jovanovic L, McGill JB. Serum 1,5-anhydroglucitol (GlycoMark): a short-term glycemic marker. Diabetes Technol Ther. 2003;5:355-363.
51. Schwedes U, Siebolds M, Mertes G, SMBG Study Group. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care. 2002;25:1928-1932.
52. Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol. 1994;31:215-219.
53. Pearson J, Bergenstal R. Fine-tuning control: pattern management versus supplementation, view 1: pattern management: an essential component of effective insulin management. Diabetes Spectrum. 2001;14:75-78.